Skip to main content
REPL logo

Replimune Group, Inc.

REPLNASDAQHealthcareBiotechnology

$12.47Today:- (-)1Y +42.40%

As of Oct 26, 2026 close

Market cap
$1.21B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.50$16.33
Volume (live)
-
Avg. volume (3M)
1.96M

Replimune Group, Inc. (REPL) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Replimune Group, Inc. stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy
Based on 8 unique analysts
(9 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$19.14
+53.49% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest REPL Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Unknown Analyst
Kempen
BuyInitiates
$19.00
Evan Seigerman
BMO Capital
BuyMaintains
$20.00
Anupam Rama
JP Morgan
BuyReiterates
$20.00 → $21.00
Robert Driscoll
Wedbush
BuyReiterates
$19.00
Roger Song
Jefferies
BuyMaintains
$24.00
Allison Bratzel
Piper Sandler
BuyMaintains
$14.00
Daina Graybosch
Leerink Partners
BuyUpgrades
$11.00 → $17.00
Daina Graybosch
Leerink Partners
BuyDowngrades
$11.00 → $17.00
Li Watsek
Cantor Fitzgerald
BuyUpgrades
-

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 11, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for REPL?

The analyst consensus rating for REPL is Buy, based on the latest ratings from 8 analysts over the last 90 days.

What is the average price target for REPL?

The average 12-month price target for REPL is $19.14, representing an upside of 53.5% from the Oct 26, 2026 close of $12.47.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.